|
Biocryst Pharmaceuticals Inc (BCRX) |
|
|
|
Biocryst Pharmaceuticals Inc 's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
With a revenue increase of 17.42% in the forth quarter 2023, year on year to cumulative value of $331 million, Biocryst Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,726,104, this marks a new company high. Within the Healthcare sector Employees of 25 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 255, from total ranking in previous quarter at 326. Biocryst Pharmaceuticals Inc has 192 employees.
What is Sales per Employee Ratio?
Select the Comparisons :
|
|
Select the Ratio:
|
|
BCRX Revenue per Employee |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
Y / Y Revenue Change |
17.42 % |
14.39 % |
25.88 % |
37.77 % |
68.68 % |
Sales per Employee
(TTM) $ |
1,726,104 |
1,653,938 |
1,597,089 |
1,508,760 |
1,410,557 |
BCRX's Total
Ranking |
# 255 |
# 326 |
# 297 |
# 412 |
# 351 |
Seq. Revenue Change |
7.68 % |
5.15 % |
19.94 % |
-13.54 % |
4.9 % |
Revenue per Employee Statistics |
High |
Average |
Low |
$ 1,726,104 |
$ 435,266 |
$ 59,990 |
(Dec 31 2023) |
|
(Jun 30 2019) |
Date modified: 2024-02-28T14:56:15+00:00
Companies with similar Revenue per Employee for 12 months ending Dec 31 2023, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Dec 31 2023 | Number of Employees Dec 31 2023 | Moderna Inc | 2,536,296.30 | $ 6,848.000 Million | 2,700 | Vertex Pharmaceuticals Inc | 2,530,564.10 | $ 9,869.200 Million | 3,900 | Shockwave Medical Inc | 2,432,806.67 | $ 729.842 Million | 300 | Gilead Sciences Inc | 1,883,055.56 | $ 27,116.000 Million | 14,400 | Inspire Medical Systems inc | 1,798,913.54 | $ 624.223 Million | 347 | Incyte Corporation | 1,764,875.36 | $ 3,695.649 Million | 2,094 | Bristol myers Squibb Company | 1,397,701.86 | $ 45,006.000 Million | 32,200 | Biolife Solutions Inc | 1,390,980.58 | $ 143.271 Million | 103 | Ptc Therapeutics inc | 1,339,745.71 | $ 937.822 Million | 700 | Regeneron Pharmaceuticals Inc | 1,265,162.04 | $ 13,117.200 Million | 10,368 | Amgen Inc | 1,164,876.03 | $ 28,190.000 Million | 24,200 | Abbvie inc | 1,086,360.00 | $ 54,318.000 Million | 50,000 | Biogen Inc | 1,023,475.55 | $ 9,835.600 Million | 9,610 | Adma Biologics Inc | 1,007,585.94 | $ 257.942 Million | 256 | Eli Lilly And Company | 974,974.29 | $ 34,124.100 Million | 35,000 | Patterson Companies Inc | 937,891.29 | $ 6,565.239 Million | 7,000 |
|